Evgen Pharma "delighted" with cash position after promising first half - Dr Huw Jones , CEO, Evgen Pharma 00:00:00
Dr Jones gives an overview of how Evgen has been performing on the operational side, highlighting clinical progress, the successful receipt of some new grant funding as well as changes to the board
